Postprandial Effects of Milk and Milk Constituents
The Effects of Milk and Milk Constituents on Postprandial Inflammation in Overweight Subjects
1 other identifier
interventional
16
1 country
1
Brief Summary
The purpose of this study is to determine whether the addition of milk or the milk constituents calcium and protein to a high-fat breakfast affects the postprandial lipid and inflammatory response.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2009
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 8, 2009
CompletedFirst Posted
Study publicly available on registry
June 10, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2009
CompletedApril 27, 2018
September 1, 2009
4 months
June 8, 2009
April 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma inflammatory markers
6 h after meal
Secondary Outcomes (1)
Serum lipids
6 h after meal
Study Arms (4)
Milk
EXPERIMENTAL500 mL low-fat milk added to high-fat meal
Protein
EXPERIMENTALMilk protein in 500 mL water added to high-fat meal
Calcium
EXPERIMENTALMilk calcium in 500 mL water added to high-fat meal
Control
EXPERIMENTALLactose in 500 mL water added to high-fat meal (control condition)
Interventions
Eligibility Criteria
You may qualify if:
- Body mass index (BMI) above 27 kg/m2
You may not qualify if:
- Smoking
- Diabetes mellitus
- Cardiovascular diseases
- Familial hypercholesterolemia or lipid lowering medication
- Severe conditions that might interfere with the study outcomes, such as COPD, asthma, rheumatoid arthritis, etc.
- Unstable body weight
- Abuse of alcohol or drugs
- Participation in another biomedical study during the past 30 days
- Having donated blood during the past 30 days
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maastricht University Medical Center
Maastricht, Netherlands
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ronald P Mensink, Prof. Dr. Ir.
Maastricht University Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2009
First Posted
June 10, 2009
Study Start
March 1, 2009
Primary Completion
July 1, 2009
Study Completion
July 1, 2009
Last Updated
April 27, 2018
Record last verified: 2009-09